Biology of Hodgkin Cell Lines

  • M. Schaadt
  • H. Burrichter
  • M. Pfreundschuh
  • E. Schell-Frederick
  • H. Tesch
  • C. Fonatsch
  • H. Stein
  • V. Diehl
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 117)


Studies to characterize Hodgkin and Reed-Sternberg cells in histological sections have yielded many conflicting data over the years. Even with progress in immunohistological technology, the histogenetic derivation of these cells remains unclear. Functional and genetic investigations are hampered by the scarcity of tumor cells in Hodgkin’s disease biopsy samples and the admixture of a variety of nonmalignant cells.


Migration Peroxi Lymphoma Leukemia Sedimentation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bieber MM, King DP, Strober S, Kaplan HS (1979) Characterization of an E-rosette inhibitor in the serum of patients with Hodgkin’s disease as a glycolipid. Clin Res 27: 81AGoogle Scholar
  2. 2.
    Breitmeyer JB (1987) Lymphocyte activation; how T cells communicate. Nature 329: 760–761PubMedCrossRefGoogle Scholar
  3. 3.
    Burrichter H, Heit W, Schaadt M, Kirchner HH, Diehl V (1983) Production of colony stimulating factors by Hodgkin cell lines. Int J Cancer 31: 269–274PubMedCrossRefGoogle Scholar
  4. 4.
    Cheng G, Minden M, Toyonaga B, Mak T, McCullogh A (1986) T-cell receptor and immunoglobulin gene rearrangements in acute myelobastic leukemia. J Exp Med 163: 414–424PubMedCrossRefGoogle Scholar
  5. 5.
    Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz H, Sueno K (1982) Characteristics of Hodgkin’s disease-derived cell lines. Cancer Treat Rep 66: 615–632PubMedGoogle Scholar
  6. 6.
    Drexler HG, Gaedicke G, Lok MS, Diehl V, Minowada J (1986) Hodgkin’s disease derived cell lines HDLM-2 and L 428. Comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10: 487–500PubMedCrossRefGoogle Scholar
  7. 7.
    Falk M, Tesch H, Stein H, Diehl V, Jones D, Fonatsch C, Bornkamm G (1987) Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin derived cell lines: activation of immature lymphoid cells in Hodgkin’s disease. Int J Cancer 40: 262–269PubMedCrossRefGoogle Scholar
  8. 8.
    Fischer RI, Bostick-Bruton F, Sander DN, Scala G, Diehl V (1983) Neoplastic cells obtained from Hodgkin’s disease are potent stimulators of human primary mixed lymphocyte cultures. J Immunol 130: 2666–2670Google Scholar
  9. 9.
    Fonatsch C, Diehl V, Schaadt M, Burrichter H, Kirchner HH (1986) Cytogenetic investigations in Hodgkin’s disease: I. Involvement of specific chromosomes in marker formation. Cancer Genet Cytogenet 20: 39–52PubMedCrossRefGoogle Scholar
  10. 10.
    Giovanella BC, Nilsson K, Zeich L, Yim O, Klein G, Stehlin JS (1979) Growth of diploid, Epstein-Barr-virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions. Int J Cancer 24: 103–113PubMedCrossRefGoogle Scholar
  11. 11.
    Jones DB, Scott CS, Wright DH, Stein H, Beverly PCL, Payne SV, Crawford DH (1985) Phenotype analysis of an established cell line derived from a patient with Hodgkin’s disease (HD). Hematol Oncol 3: 133–145PubMedCrossRefGoogle Scholar
  12. 12.
    Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shiragawa S, Hatanaka M, Honjo T (1986) Cytochemical, immunologic, chromosomal and molecular genetic analysis of a novel cell line derived from Hodgkin’s disease. Blood 68: 285–292PubMedGoogle Scholar
  13. 13.
    Kortmann C, Burrichter H, Jahn G, Diehl V, Peter HH (1984) Interleukin-1 activity constitutively generated by Hodgkin derived cell lines. I. Measurement in a human lymphocyte costimulator assay. Immunobiology 166: 318–333PubMedCrossRefGoogle Scholar
  14. 14.
    Lozzio BB, Lozzio CB, Machado E (1976) Human myelogenous (Ph1 +) leukemia cell-line; transplantation into athymic mice. JNCI 56: 627–628PubMedGoogle Scholar
  15. 15.
    Meuer S, Hussey R, Fabbi M, Fox D, Acuto O, Fitzgerald K, Hodgdon J, Protentis J, Schlossman S, Reinherz E (1984) An alternative pathway of T-cell activation: a functional role for the 50 kd T 11 sheep erythrocyte receptor protein. Cell 36: 897–906PubMedCrossRefGoogle Scholar
  16. 16.
    Newcom S, Kadin ME, Ansari AA (1988) Production of transforming growth factor beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol 131 (3): 569–577PubMedGoogle Scholar
  17. 17.
    Olsson L, Behnke O, Pleibel N, D’Amore F, Werdelin O, Fry KE, Kaplan HS (1984) Establishment and characterization of a clonal gaint cell line from a patient with Hodgkin’s disease. JNCI 73: 809–830PubMedGoogle Scholar
  18. 18.
    Pfreundschuh M, Mommerz E, Meissner M, Feller A, Hassa R, Krueger HR, Diehl V (1988) Hodgkin and Reed-Sternberg cells associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin. Anticancer Res 8: 217–224PubMedGoogle Scholar
  19. 19.
    Poppema S, De Jong B, Atmosoerodjo J, Idenburg V, Visser L, De Ley L (1985) Morphologic, immunologic, enzyme histochemical and chromosomal analysis of a cell line derived from Hodgkin’s disease. Evidence for a B-cell origin of Sternberg-Reed cells. Cancer 55: 683–690PubMedCrossRefGoogle Scholar
  20. 20.
    Schaadt M, Kirchner H, Fonatsch C, Diehl V (1979) Intracranial heterotransplantation of human hematopoetic cells in “nude”-mice. Int J Cancer 23: 751–561PubMedCrossRefGoogle Scholar
  21. 21.
    Schaadt M, Diehl V, Stein H, Fonatsch C, Kirchner H (1980) Two neoplastic cell lines with unique features derived from Hodgkin’s disease. Int J Cancer 26: 723–731PubMedCrossRefGoogle Scholar
  22. 22.
    Schell-Frederick E, Radtke H, Sommer H, Helbing I, Burrichter H, Schaadt M, Diehl V (1988) Inhibition of human neutrophil migration by supernatants from Hodgkin’s disease derived cell lines. Eur Clin Invest 18: 290–296CrossRefGoogle Scholar
  23. 23.
    Schwab U, Stein H, Gerdes J, Lemke H, Kirchner HH, Schaadt M, Diehl V (1982) Production of a monoclonal antibody specific for Hodgkin-and Sternberg-Reed-cells of Hodgkin’s lymphoma and a subset of normal lymphoid cells. Nature 299: 65–67PubMedCrossRefGoogle Scholar
  24. 24.
    Stein H, Gerdes J, Schwab U, Lemke H, Mason DY, Ziegler A, Schienle W, Diehl V (1982) Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly detected small-cell population. Int J Cancer 30: 445–459PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1989

Authors and Affiliations

  • M. Schaadt
    • 1
  • H. Burrichter
    • 1
  • M. Pfreundschuh
    • 1
  • E. Schell-Frederick
    • 1
  • H. Tesch
    • 1
  • C. Fonatsch
    • 1
  • H. Stein
    • 1
  • V. Diehl
    • 1
  1. 1.Medizinische Klinik IUniversität KölnKölnGermany

Personalised recommendations